International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
American Institute of the City of New York American Institute of the City of New York The American Institute of the City of New York, or, The American Institute of the City of New York for the Encouragement of Science and Invention was a civic organization that existed from ca. 1838 – ca. 1930. The institute was an association of inventors. It organized exhibitions, lectures and radio broadcasts to inform the public about new technologies, and served as a locus for inventors’ professional activities. The American Institute of the City of New York was chartered on 2 May 1829. Eventually, the American Institute was merged with the New